1. Home
  2. TWO vs CTMX Comparison

TWO vs CTMX Comparison

Compare TWO & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Two Harbors Investment Corp

TWO

Two Harbors Investment Corp

HOLD

Current Price

$10.97

Market Cap

1.0B

Sector

Real Estate

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.23

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TWO
CTMX
Founded
2009
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
977.1M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
TWO
CTMX
Price
$10.97
$4.23
Analyst Decision
Hold
Strong Buy
Analyst Count
7
10
Target Price
$12.94
$12.10
AVG Volume (30 Days)
4.9M
10.8M
Earning Date
04-27-2026
05-11-2026
Dividend Yield
12.43%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$76,201,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.75
P/E Ratio
N/A
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$8.84
$0.48
52 Week High
$14.17
$8.21

Technical Indicators

Market Signals
Indicator
TWO
CTMX
Relative Strength Index (RSI) 53.96 42.66
Support Level $9.60 $3.89
Resistance Level $11.05 $4.54
Average True Range (ATR) 0.23 0.34
MACD 0.05 -0.01
Stochastic Oscillator 52.48 14.49

Price Performance

Historical Comparison
TWO
CTMX

About TWO Two Harbors Investment Corp

Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: